Inclarity on dose adjustment in renal impairment;Otydligt om läkemedelsdosering vid nedsatt njurfunktion

Lakartidningen

Volumn 110, Issue 21, 2013, Pages 1030-

  Asker Hagelberg, Charlotte ^b   Rydberg, Diana ^b   Hentschke, Maria ^b   Holm, Lennart ^b   Rosenborg, Staffan ^a   Elinder, Carl Gustaf ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Stockholms läns landsting ^*

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; CLASSIFICATION; DRUG INFORMATION; DRUG LABELING; HUMAN; KIDNEY; KIDNEY FAILURE; MEDICAL LITERATURE; METABOLISM; PHARMACOKINETICS; STANDARD;

CATALOGS, DRUG; DRUG INFORMATION SERVICES; DRUG LABELING; HUMANS; KIDNEY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PHARMACOPOEIAS AS TOPIC; RENAL INSUFFICIENCY;

EID: 84878218409     PISSN: 00237205     EISSN: 16527518     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Glassock R. The GFR decline with aging: A sign of normal senescence, not disease. Nephrology Times. 2009;2:6-8.
2. Abdelhafiz AH, Brown SH, Bello A, et al. Chronic kidney disease in older people: physiology, pathology or both? Nephron Clin Pract. 2010;116:c19-24.
3. Blix HS, Viktil KK, Moger TA, et al. Use of renal risk drugs in hospitalized patients with impaired renal function-an underestimated problem? Nephrol Dial Transplant. 2006;21:3164-71.
4. Fryckstedt J, Asker-Hagelberg C. Läkemedelsrelaterade problem vanliga på medicinakuten. Orsak till inläggning hos nästan var tredje patient, enligt kvalitetsuppföljning. Läkartidningen. 2008;105: 894-8.
5. Grubb A. Tools for calculating robust cystatin C-and creatininebased estimates of relative GFR and for calculating absolute GFR from relative GFR. Lund: Lunds universitet; 2011. http://www. eGFR.se
6. Skattning av njurfunktion. En systematisk litteraturöversikt. Stockholm: SBU; 2012. SBU-rapport nr 214.
7. Heimbürger O, Bárány P. Välj rätt metod för beräkning av njurfunktion. Frågeställningen avgör vilken metod som bör användas. Läkartidningen. 2009;106:420-1.
8. Christensson A, Elmståhl S. Estimation of the age-dependent decline of glomerular filtration rate from formulas based on creatinine and cystatin C in the general elderly population. Nephron Clin Pract. 2011;117:c40-50.
9. Gustafsson LL, Wettermark B, Godman B, et al. The 'wise list'-a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol. 2011;108:224-33.
10. LÄKSAK-Läkemedelssakkunniga i Stockholms län. Kloka Listan 2010. http://www.janusinfo.se/ Global/Kloka procent20listan/ kloka_listan_2010.pdf.
11. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function; 2004 [citerad 25 jan 2013]. http:// www.emea.europa.eu/docs/en_ GB/document_library/Scientific_ guideline/2009/09/ WC500003123.pdf.
12. Elinder CG, Allander SV, Farrokhnia N. Skattning av njurfunktion-oklart vad som är bästa metod. Bakgrund till SBU:s granskning av endogena markörer. Läkartidningen. 2010;107:3138-40.
13. Corsonello A, Pedone C, Lattanzio F, et al. Association between glomerular filtration rate and adverse drug reactions in elderly hospitalized patients: the role of the estimating equation. Drugs Aging. 2011;28:379-90.
14. Roberts GW, Ibsen PM, Schioler CT. Modified diet in renal disease method overestimates renal function in selected elderly patients. Age Ageing. 2009;38:698-703.
15. Zhang L, Xu N, Xiao S, et al. Regulatory perspectives on designing pharmacokinetic studies and optimizing labeling recommendations for patients with chronic kidney disease. J Clin Pharmacol. 2012;52:79S-90S.